Compare NBTB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTB | LMAT |
|---|---|---|
| Founded | 1856 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 1995 | 2006 |
| Metric | NBTB | LMAT |
|---|---|---|
| Price | $52.62 | $101.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $51.33 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 398.0K | 251.0K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.39% | 0.93% |
| EPS Growth | 12.12 | ★ 30.57 |
| EPS | ★ 0.98 | 0.68 |
| Revenue | $182,952,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $16.82 | $14.21 |
| Revenue Next Year | $4.88 | $8.88 |
| P/E Ratio | ★ $53.97 | $150.33 |
| Revenue Growth | 10.40 | ★ 13.53 |
| 52 Week Low | $39.21 | $79.40 |
| 52 Week High | $54.50 | $118.01 |
| Indicator | NBTB | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 61.65 | 52.46 |
| Support Level | $50.74 | $95.41 |
| Resistance Level | $53.33 | $105.17 |
| Average True Range (ATR) | 1.22 | 3.57 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 62.17 | 58.26 |
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.